Related Experiment Video

Updated: Aug 16, 2026

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases

Tom Hsun-Wei Huang1, Valentina Razmovski-Naumovski, Bhavani Prasad Kota

  • 1Faculty of Pharmacy, A15, University of Sydney, New South Wales, 2006, Australia. tomh@pharm.usyd.edu.au

Respiratory Research
|September 13, 2005
PubMed

Insights

Novel therapies targeting peroxisome proliferator-activated receptor-gamma (PPARG) show promise for chronic respiratory diseases like asthma and COPD. PPARG ligands may offer new treatment avenues for lung conditions.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Pharmacology

Background:

  • Respiratory diseases require novel therapeutic strategies.
  • Peroxisome proliferator-activated receptor (PPAR) involvement in inflammation is known from cardiovascular disease and diabetes.
  • The potential application of PPAR knowledge to lung diseases is under investigation.

Purpose of the Study:

  • To explore peroxisome proliferator-activated receptor-gamma (PPARG) as a potential therapeutic target for lung diseases.
  • To investigate PPARG's role as a marker and treatment focal point in conditions including asthma, COPD, lung cancer, and cystic fibrosis.

Main Methods:

  • Review of existing research on PPARG and inflammatory pathways.
  • Analysis of PPARG's relevance to the pathophysiology of major human airway diseases.

Main Results:

  • PPARG is implicated in the inflammatory processes relevant to chronic respiratory diseases.
  • PPARG ligands demonstrate potential for therapeutic intervention in lung conditions.

Conclusions:

  • PPARG represents a promising target for novel therapies in respiratory medicine.
  • PPARG ligands may yield valuable mechanistic insights and new treatment options for patients with chronic lung diseases.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...